CN115058432B - Tobacco NtWRKY51 gene and application thereof in regulation and control of bacterial wilt resistance of tobacco - Google Patents
Tobacco NtWRKY51 gene and application thereof in regulation and control of bacterial wilt resistance of tobacco Download PDFInfo
- Publication number
- CN115058432B CN115058432B CN202110251034.8A CN202110251034A CN115058432B CN 115058432 B CN115058432 B CN 115058432B CN 202110251034 A CN202110251034 A CN 202110251034A CN 115058432 B CN115058432 B CN 115058432B
- Authority
- CN
- China
- Prior art keywords
- tobacco
- gene
- ntwrky51
- bacterial wilt
- resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 110
- 241000208125 Nicotiana Species 0.000 title claims abstract description 94
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 66
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 62
- 230000033228 biological regulation Effects 0.000 title abstract description 5
- 239000013598 vector Substances 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 10
- 238000000034 method Methods 0.000 abstract description 20
- 244000061176 Nicotiana tabacum Species 0.000 abstract description 16
- 230000014509 gene expression Effects 0.000 abstract description 10
- 238000011081 inoculation Methods 0.000 abstract description 9
- 238000009395 breeding Methods 0.000 abstract description 5
- 230000001488 breeding effect Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 244000052769 pathogen Species 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 230000001276 controlling effect Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000003938 response to stress Effects 0.000 abstract 1
- 241000589158 Agrobacterium Species 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 230000002018 overexpression Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000010839 reverse transcription Methods 0.000 description 6
- 230000009261 transgenic effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 241001002356 Valeriana edulis Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000008653 root damage Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- NNMUHYLAYUSTTN-FXQIFTODSA-N Asn-Gln-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O NNMUHYLAYUSTTN-FXQIFTODSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 241000589771 Ralstonia solanacearum Species 0.000 description 2
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- OILNWMNBLIHXQK-ZLUOBGJFSA-N Ala-Cys-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O OILNWMNBLIHXQK-ZLUOBGJFSA-N 0.000 description 1
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 1
- CJQAEJMHBAOQHA-DLOVCJGASA-N Ala-Phe-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CJQAEJMHBAOQHA-DLOVCJGASA-N 0.000 description 1
- KGSJCPBERYUXCN-BPNCWPANSA-N Arg-Ala-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KGSJCPBERYUXCN-BPNCWPANSA-N 0.000 description 1
- QBQVKUNBCAFXSV-ULQDDVLXSA-N Arg-Lys-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QBQVKUNBCAFXSV-ULQDDVLXSA-N 0.000 description 1
- FGYUMGXLCZYNQG-UBHSHLNASA-N Asn-Cys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)N)C(O)=O)=CNC2=C1 FGYUMGXLCZYNQG-UBHSHLNASA-N 0.000 description 1
- SJPZTWAYTJPPBI-GUBZILKMSA-N Asn-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SJPZTWAYTJPPBI-GUBZILKMSA-N 0.000 description 1
- JQSWHKKUZMTOIH-QWRGUYRKSA-N Asn-Gly-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N JQSWHKKUZMTOIH-QWRGUYRKSA-N 0.000 description 1
- ZJIFRAPZHAGLGR-MELADBBJSA-N Asn-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZJIFRAPZHAGLGR-MELADBBJSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 1
- AMGQTNHANMRPOE-LKXGYXEUSA-N Asn-Thr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O AMGQTNHANMRPOE-LKXGYXEUSA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- 101150069409 CDS gene Proteins 0.000 description 1
- LMXOUGMSGHFLRX-CIUDSAMLSA-N Cys-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CS)N LMXOUGMSGHFLRX-CIUDSAMLSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WUAYFMZULZDSLB-ACZMJKKPSA-N Gln-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O WUAYFMZULZDSLB-ACZMJKKPSA-N 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- WPLGNDORMXTMQS-FXQIFTODSA-N Glu-Gln-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O WPLGNDORMXTMQS-FXQIFTODSA-N 0.000 description 1
- OPAINBJQDQTGJY-JGVFFNPUSA-N Glu-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)O)N)C(=O)O OPAINBJQDQTGJY-JGVFFNPUSA-N 0.000 description 1
- ALMBZBOCGSVSAI-ACZMJKKPSA-N Glu-Ser-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ALMBZBOCGSVSAI-ACZMJKKPSA-N 0.000 description 1
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 1
- AQLHORCVPGXDJW-IUCAKERBSA-N Gly-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN AQLHORCVPGXDJW-IUCAKERBSA-N 0.000 description 1
- JLJLBWDKDRYOPA-RYUDHWBXSA-N Gly-Gln-Tyr Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JLJLBWDKDRYOPA-RYUDHWBXSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- FJWSJWACLMTDMI-WPRPVWTQSA-N Gly-Met-Val Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O FJWSJWACLMTDMI-WPRPVWTQSA-N 0.000 description 1
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 1
- ZPVJJPAIUZLSNE-DCAQKATOSA-N His-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O ZPVJJPAIUZLSNE-DCAQKATOSA-N 0.000 description 1
- MDBYBTWRMOAJAY-NHCYSSNCSA-N His-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MDBYBTWRMOAJAY-NHCYSSNCSA-N 0.000 description 1
- NKRWVZQTPXPNRZ-SRVKXCTJSA-N His-Met-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC1=CN=CN1 NKRWVZQTPXPNRZ-SRVKXCTJSA-N 0.000 description 1
- YAEKRYQASVCDLK-JYJNAYRXSA-N His-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N YAEKRYQASVCDLK-JYJNAYRXSA-N 0.000 description 1
- KDDKJKKQODQQBR-NHCYSSNCSA-N His-Val-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N KDDKJKKQODQQBR-NHCYSSNCSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- SCHZQZPYHBWYEQ-PEFMBERDSA-N Ile-Asn-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SCHZQZPYHBWYEQ-PEFMBERDSA-N 0.000 description 1
- IXEFKXAGHRQFAF-HVTMNAMFSA-N Ile-Glu-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N IXEFKXAGHRQFAF-HVTMNAMFSA-N 0.000 description 1
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 1
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 1
- DGTOKVBDZXJHNZ-WZLNRYEVSA-N Ile-Thr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N DGTOKVBDZXJHNZ-WZLNRYEVSA-N 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- CQGSYZCULZMEDE-SRVKXCTJSA-N Leu-Gln-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O CQGSYZCULZMEDE-SRVKXCTJSA-N 0.000 description 1
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 1
- DCGXHWINSHEPIR-SRVKXCTJSA-N Leu-Lys-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)N DCGXHWINSHEPIR-SRVKXCTJSA-N 0.000 description 1
- XWEVVRRSIOBJOO-SRVKXCTJSA-N Leu-Pro-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O XWEVVRRSIOBJOO-SRVKXCTJSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 1
- ZJWIXBZTAAJERF-IHRRRGAJSA-N Lys-Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZJWIXBZTAAJERF-IHRRRGAJSA-N 0.000 description 1
- WZVSHTFTCYOFPL-GARJFASQSA-N Lys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N)C(=O)O WZVSHTFTCYOFPL-GARJFASQSA-N 0.000 description 1
- QVTDVTONTRSQMF-WDCWCFNPSA-N Lys-Thr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CCCCN QVTDVTONTRSQMF-WDCWCFNPSA-N 0.000 description 1
- DZTDEZSHBVRUCQ-FXQIFTODSA-N Met-Asp-Cys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N DZTDEZSHBVRUCQ-FXQIFTODSA-N 0.000 description 1
- GETCJHFFECHWHI-QXEWZRGKSA-N Met-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCSC)N GETCJHFFECHWHI-QXEWZRGKSA-N 0.000 description 1
- NHXXGBXJTLRGJI-GUBZILKMSA-N Met-Pro-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NHXXGBXJTLRGJI-GUBZILKMSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- WMGVYPPIMZPWPN-SRVKXCTJSA-N Phe-Asp-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N WMGVYPPIMZPWPN-SRVKXCTJSA-N 0.000 description 1
- RJYBHZVWJPUSLB-QEWYBTABSA-N Phe-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N RJYBHZVWJPUSLB-QEWYBTABSA-N 0.000 description 1
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
- AFNJAQVMTIQTCB-DLOVCJGASA-N Phe-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 AFNJAQVMTIQTCB-DLOVCJGASA-N 0.000 description 1
- GLJZDMZJHFXJQG-BZSNNMDCSA-N Phe-Ser-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLJZDMZJHFXJQG-BZSNNMDCSA-N 0.000 description 1
- KDIIENQUNVNWHR-JYJNAYRXSA-N Pro-Arg-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KDIIENQUNVNWHR-JYJNAYRXSA-N 0.000 description 1
- SKICPQLTOXGWGO-GARJFASQSA-N Pro-Gln-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N2CCC[C@@H]2C(=O)O SKICPQLTOXGWGO-GARJFASQSA-N 0.000 description 1
- AUQGUYPHJSMAKI-CYDGBPFRSA-N Pro-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 AUQGUYPHJSMAKI-CYDGBPFRSA-N 0.000 description 1
- JDJMFMVVJHLWDP-UNQGMJICSA-N Pro-Thr-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JDJMFMVVJHLWDP-UNQGMJICSA-N 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 1
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 1
- DSGYZICNAMEJOC-AVGNSLFASA-N Ser-Glu-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DSGYZICNAMEJOC-AVGNSLFASA-N 0.000 description 1
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 1
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 1
- LYGKYFKSZTUXGZ-ZDLURKLDSA-N Thr-Cys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(O)=O LYGKYFKSZTUXGZ-ZDLURKLDSA-N 0.000 description 1
- UCCNDUPVIFOOQX-CUJWVEQBSA-N Thr-Cys-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 UCCNDUPVIFOOQX-CUJWVEQBSA-N 0.000 description 1
- UHBPFYOQQPFKQR-JHEQGTHGSA-N Thr-Gln-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UHBPFYOQQPFKQR-JHEQGTHGSA-N 0.000 description 1
- ZTPXSEUVYNNZRB-CDMKHQONSA-N Thr-Gly-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZTPXSEUVYNNZRB-CDMKHQONSA-N 0.000 description 1
- CJXURNZYNHCYFD-WDCWCFNPSA-N Thr-Lys-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O CJXURNZYNHCYFD-WDCWCFNPSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 1
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 1
- BEZTUFWTPVOROW-KJEVXHAQSA-N Thr-Tyr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O BEZTUFWTPVOROW-KJEVXHAQSA-N 0.000 description 1
- HXNVJPQADLRHGR-JBACZVJFSA-N Trp-Glu-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N HXNVJPQADLRHGR-JBACZVJFSA-N 0.000 description 1
- MPKPIWFFDWVJGC-IRIUXVKKSA-N Tyr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O MPKPIWFFDWVJGC-IRIUXVKKSA-N 0.000 description 1
- NVZVJIUDICCMHZ-BZSNNMDCSA-N Tyr-Phe-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O NVZVJIUDICCMHZ-BZSNNMDCSA-N 0.000 description 1
- AUZADXNWQMBZOO-JYJNAYRXSA-N Tyr-Pro-Arg Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 AUZADXNWQMBZOO-JYJNAYRXSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 1
- YLRAFVVWZRSZQC-DZKIICNBSA-N Val-Phe-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N YLRAFVVWZRSZQC-DZKIICNBSA-N 0.000 description 1
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000012881 co-culture medium Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 108010091871 leucylmethionine Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000012883 rooting culture medium Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention discloses a tobacco NtWRKY51 gene and application thereof in regulating and controlling bacterial wilt resistance of tobacco. The tobacco NtWRKY51 gene is inoculated with bacterial wilt pathogen bacterial wilt bacteria to induce expression, and participates in stress response of the tobacco wilt. After artificial inoculation of bacterial wilt, tobacco plants overexpressed by the NtWRKY51 gene show stronger resistance to bacterial wilt than K326. The tobacco NtWRKY51 gene plays an important role in the resistance regulation process of tobacco bacterial wilt, and can be applied to gene function research and genetic engineering breeding for improving the resistance of tobacco bacterial wilt.
Description
Technical Field
The invention belongs to the technical field of tobacco genetic engineering, and particularly relates to a tobacco NtWRKY51 gene related to plant bacterial wilt resistance and application thereof in regulation and control of the tobacco bacterial wilt resistance.
Background
Bacterial wilt of tobacco is a bacterial soil-borne disease caused by ralstonia solanacearum (Ralstonia solanancearum), and occurs in the seedling stage and the field stage of tobacco, so that the growth and development of tobacco are seriously affected, and serious economic loss is caused to tobacco production. The prevention and treatment of tobacco bacterial wilt include chemical, agricultural and biological prevention and treatment methods, and the problems can not be effectively solved by the methods at present. In crops such as tobacco, excavation and utilization of a bacterial wilt resistance gene are fundamental approaches for controlling bacterial wilt. The related genes of bacterial wilt resistance are separated from tobacco by utilizing related genetic engineering technology and are applied to bacterial wilt resistance tobacco molecular breeding, so that the method has important practical significance for guaranteeing the quality and yield of tobacco.
The WRKY transcription factor family is a family of plant-specific transcription factors whose family members have 1 or 2 highly conserved WRKY domains (WRKYGQKs) at the N-terminus, the nomenclature of which also derives from this domain. The invention discovers a WRKY transcription factor related to tobacco bacterial wilt resistance, namely a tobacco NtWRKY51 gene, and provides a new way for tobacco bacterial wilt resistance.
Disclosure of Invention
The primary aim of the invention is to provide a tobacco NtWRKY51 gene related to tobacco bacterial wilt resistance, and a recombinant over-expression vector constructed by the tobacco NtWRKY51 gene related to tobacco bacterial wilt resistance is utilized to transform tobacco, so that the expression level of the NtWRKY51 gene is improved, and the resistance of the tobacco to bacterial wilt can be further enhanced, thereby providing a breeding intermediate material for improving the tobacco bacterial wilt resistance and tobacco bacterial wilt resistance breeding.
The tobacco NtWRKY51 gene has a gene CDS sequence shown in SEQ ID NO. 1.
Further, the gene sequence also comprises a gene sequence with a similarity of not less than 95% and a similar function; such similar functions include expression of proteins resistant to bacterial wilt.
Further, the specific object for resisting bacterial wilt is tobacco.
The second purpose of the invention is to provide an NtWRKY51 protein, and the protein sequence is shown as SEQ ID NO. 2.
Further, the protein sequence also comprises a protein sequence with a similarity of not less than 95% and a similar function; similar functions include resistance to bacterial wilt.
Further, the specific object for resisting bacterial wilt is tobacco.
The third object of the invention is to provide the application of the tobacco NtWRKY51 gene in improving bacterial wilt resistance.
Further, the tobacco additive is used for improving the bacterial wilt resistance of tobacco.
Further, tobacco transformed plants with improved resistance to tobacco bacterial wilt are obtained by over-expressing the tobacco NtWRKY51 gene.
Further, the vector overexpressing the tobacco NtWRKY51 gene is pCHF3.
The recombinant overexpression vector pCHF3 is a binary agrobacterium vector. When constructing the recombinant expression vector, the nucleotide sequence of the CDS gene NtWRKY51 is inserted into the cauliflower mosaic virus (CAMV) 35S promoter.
The transformed tobacco is prepared by infecting tobacco callus by using agrobacterium containing a recombinant overexpression vector, and integrating a cauliflower mosaic virus 35S promoter and a tobacco NtWRKY51 gene into a tobacco genome by using an agrobacterium-mediated transformation method. In tobacco, bacterial wilt resistance of tobacco is improved by over-expression of the NtWRKY51 gene.
The invention completes cloning, expression and functional analysis of the NtWRKY51 gene in tobacco for the first time, and analysis results show that the gene is related to bacterial wilt resistance response of the tobacco. In addition, the over-expression of the NtWRKY51 gene in the tobacco can obviously improve the bacterial wilt resistance of the tobacco, thereby providing materials for improving the bacterial wilt resistance of the tobacco and breeding the bacterial wilt resistance of the tobacco.
Drawings
FIG. 1 shows an electrophoresis chart of PCR amplification products of tobacco NtWRKY51 gene clone;
m in FIG. 1 is a 2000bp DNA maker;1 is the result of amplification of the NtWRKY51 gene; 2 is a negative control.
FIG. 2 analysis of the expression pattern of the NtWRKY51 gene after tobacco inoculation with bacterial wilt;
mock in fig. 2 represents a control;
FIG. 3 analysis of the expression level of NtWRKY51 in tobacco plants over-expressed with the tobacco NtWRKY51 gene;
FIG. 4 evaluation of bacterial wilt resistance of tobacco NtWRKY51 gene over-expressed tobacco plants and K326 control;
FIG. 5 tobacco root bacterial wilt pathogen propagation status of tobacco plants over-expressed with the tobacco NtWRKY51 gene and K326 control.
Detailed Description
The present application is further illustrated below in conjunction with examples, without limiting the invention; before describing the specific embodiments, the following will briefly describe the basic conditions of some biological materials, experimental reagents, experimental instruments, etc. involved in the following embodiments.
Biological material:
tobacco material, cultivar K326 of tobacco (Nicotiana tabacum) was stored in the laboratory. The vector plasmid pCHF3 used for the overexpression of the tobacco gene was stored in the laboratory and referenced by the vector construction method (https:// www.mdpi.com/2073-4409/8/1/50).
Experimental reagent:
the reagents and kits used in the development process of the experiment are as follows: restriction enzymes were purchased from NEB (beijing) limited; the RNA extraction TRIzol kit was purchased from kang century biotechnology limited; high-fidelity DNA amplification enzyme, reverse transcription kit and fluorescent quantitative kit are purchased from Nanjinouzan biotechnology Co., ltd; DNA gel recovery kit MiniBEST Agarose Gel DNA Extraction Kit, plasmid DNA miniprep kit MiniBEST Plasmid purification Kit were purchased from Invitrogen corporation; antibiotics such as kanamycin and rifampicin were purchased from Shanghai Biotechnology Inc.
Example 1
This example is briefly described below mainly in terms of the process of obtaining the NtWRKY51 gene.
1. Total RNA extraction
RNA is extracted by adopting a TRIzol reagent extraction method of century company, and the method comprises the following specific steps: under normal growth conditions, quickly grinding the grown tobacco K326 material in liquid nitrogen into powder, adding 1ml TRIzon Reagent (cWbiotech) into 30-50mg tissue, and mixing; after 5min at room temperature, 200. Mu.l of chloroform was added and the mixture was vigorously shaken for 15 seconds and allowed to stand at room temperature for 2min. Centrifuge at 12,000rpm for 10 minutes at 4℃and carefully remove the upper aqueous phase, transfer to another centrifuge tube and add an equal volume of 70% ethanol. The whole mixture was transferred to an adsorption column, centrifuged at 12,000rpm for 20 seconds, the waste liquid in the collection tube was discarded, 700. Mu.l Buffer RW1 was added, and centrifuged at 12,000rpm for 20 seconds, and the waste liquid in the collection tube was discarded. Mu.l Buffer RW2 was added and centrifuged at 12,000rpm for 20 seconds to pour out the waste liquid in the collection tube. Air-separating for 2min, pouring out the waste liquid in the collecting tube, standing at room temperature for 5min, adding 30 μl of water, standing at room temperature for 1min, centrifuging at 12,000rpm for 1min, collecting RNA solution, and preserving RNA at-70deg.C to prevent degradation. The RNA extracted was treated with DNase (Fermentas).
2. Reverse transcription reaction
The reverse transcription step adopts an R323 kit of Norwegian company, and comprises the following specific steps: taking 1 mu g K326 total RNA for reverse transcription, adding 4 XgDNA wind Mix 4 mu l, adding deionized water to make up to 16 mu l; after 2min incubation at 42℃4. Mu.l of 5X HiScript III qRT SuperMix were added, the final volume of the reaction was 20. Mu.l; the reaction was terminated by heating at 37℃for 15min and 85℃for 5 s. The obtained cDNA was stored at-20 ℃.
3. Identification and cloning of the NtWRKY51 Gene
By analyzing transcriptome data before and after bacterial wilt inoculation of tobacco, a tobacco gene NtWRKY51 with significantly up-regulated expression level after bacterial wilt inoculation is found. Tobacco genome database in solanaceae genome website of tobacco NtWRKY51 gene
(ftp:// ftp. Software. Net/genome/nicotiana_tabacum/edwards_et al_2017) accession No. Nitab4.5_0006656g0060.1, the gene was annotated to encode a WRKY transcription factor, the specific function was unknown.
PCR amplification refers to the In-fisuon method of Clontech company, a pair of primers are artificially synthesized, 20bp carrier sequences are respectively added at the 5 'end and the 3' end of the primers, and the carrier sequence is F5'-AGAACACGGGGGACGAGCTC-3' and is shown as SEQ ID NO. 3; r is 5'-GATCCCCGGGTACCGAGCTC-3' and is shown as SEQ ID NO. 4.
The upstream primer and the downstream primer are as follows:
NtWRKY51-F:5 '-ATGGATTGTGCTTTCAATTGGG', as shown in SEQ ID NO.5,
NtWRKY51-R:5 '-TCATGAGAAAAATCTGGGGTTA' as shown in SEQ ID NO. 6;
PCR amplification was performed using the whole tobacco seedling cDNA of K326 variety as a template, and NtWRKY51-F and NtWRKY51-R as primers, using high fidelity 2X Phanta Max Master Mix (Dye Plus) (Vazyme); the 50 μl reaction system was designed as follows:
the reaction procedure is 95 ℃ for 3min of pre-denaturation; 95 ℃ for 15s;56 ℃ for 15s;72 ℃ for 1min;35 cycles, and finally extending at 72 ℃ for 5min; after completion of the reaction, the PCR results were detected by electrophoresis (FIG. 1). After electrophoresis, the target gene fragment was recovered by gel cutting under ultraviolet irradiation and gel recovery kit (TAKARA). Sequencing the recovered amplified product to obtain NtWRKY51 gene, wherein the NtWRKY51 gene comprises 996bp base, and the base sequence of the NtWRKY51 gene is shown as SEQ ID NO. 1.
Example 2
Analysis of expression pattern of NtWRKY51 Gene after bacterial wilt of tobacco seed
Bacterial wilt disease is carried out on tobacco cultivar K326 plants. Root injury treatment is carried out before bacterial wilt pathogen inoculation. The root injury treatment is specifically implemented by transplanting tobacco seedlings which are cultivated indoors to a three-leaf-one-heart size into a seedling pot with a caliber of 9cm, and then inoculating bacterial wilt when the tobacco seedlings are cultivated to four-leaf-one-heart sizes. Before the preparation and the bacterial wilt are used for treating tobacco plants, root injury pretreatment is carried out, namely, one third of the tobacco roots are cut off by sharp scissors and then transplanted into a flowerpot again. The bacterial wilt specific inoculation method and process are that the preserved bacterial wilt strain CQPS-1 is taken out from a refrigerator with ultralow temperature of minus 80 ℃, NB culture medium is prepared, bacterial wilt is inoculated on an ultra-clean workbench, and the bacterial wilt is cultured at 28 ℃/220rpm overnight. And (3) inoculating 10mL of bacterial suspension with the concentration of about 108cfu/mL at the periphery of the root of each tobacco seedling by adopting a root irrigation inoculation method. And (3) regulating the environment temperature to 30 ℃ and regulating the environment humidity to 80% for culture. Subsequently, a disease investigation was performed and the propagation of ralstonia solanacearum in tobacco roots was examined after 0, 2, 4, 6 days, respectively. The method of example 1 was used to extract RNA from roots of diseased tobacco and to extract RNA from roots of non-diseased tobacco at the same time as the control. The extracted RNA was reverse transcribed to obtain cDNA, and real-time quantitative PCR detection was performed using specific primers for NtWRKY51 using the cDNA as a template (reverse transcription procedure was the same as in example 1), and the primer sequences were as follows:
the real-time quantitative primer F TGAAAATCTGATGATAGGTGGCGG is shown as SEQ ID NO.7,
the real-time quantitative primer R AACTTGTTGAGGAAGTGTTGGCTG is shown as SEQ ID NO.8
The results showed that the expression of the NtWRKY51 gene was significantly up-regulated 6 days after bacterial wilt inoculation (fig. 2), approximately 43.1-fold of the control.
Example 3
Using the NtWRKY51 gene obtained in example 1, the inventors further constructed an overexpression vector pCHF3-NtWRKY51 for transformation, and the related procedures are briefly described below.
First, the NtWRKY51 gene obtained In example 1 was ligated with the pCHF3 plasmid digested with SacI, and 10. Mu.L of a reaction system was established as required by the kit by referring to the In-fusion seamless ligation protocol of Clontech: 5x in-fusion 2 μl; 4. Mu.l of pCHF3 (SacI cleavage); 4. Mu.L of NtWRKY51 gene amplification product; at 50℃for 15min, put on ice for the next transformation. The connection product is transformed into escherichia coli competent cells by adopting a heat shock method, and the specific process is as follows: adding 2 μl of the ligation product into competent cells under aseptic conditions, gently mixing, and ice-bathing for 30min; heat shock at 42 ℃ for 90s, rapidly transferring the centrifuge tube into an ice bath, and placing for 2-3min; 800 μl of LB culture medium without antibiotics is added, and the shaking table is gently shaken for about 1h at 37 ℃; 200 μl of the culture broth was applied to LB solid medium containing 100 μg/ml spectinomycin, and cultured upside down at 37℃for 12-16h.
White bacterial plaques grow in the culture medium, the white bacterial plaques are inoculated into LB liquid culture medium containing 100 mug/ml spectinomycin for 12-16 hours of shaking culture, and PCR verification is carried out by using self primers and carrier primers, wherein the sequences of the primers are as follows:
self primer: TGAAAATCTGATGATAGGTG, as shown in SEQ ID NO. 9;
vector primer: GTGTGTGCGCAATGAAACTG, as shown in SEQ ID NO. 10;
the positive clones with correct results were further sequenced by company to ensure that the recombinant plasmid was constructed correctly.
Example 4
The pCHF3-NtWRKY51 vector prepared in example 3 was transformed into Agrobacterium GV3101 (purchased from Beijing full-scale gold biotechnology Co., ltd.) by a heat shock method, and single colonies were selected for PCR verification to confirm successful transformation of the expression vector pCHF3-NtWRKY51 into Agrobacterium.
Transforming tobacco plants:
the transgenic tobacco plants are obtained by adopting an agrobacterium-mediated leaf disc transformation method, and the specific steps are as follows:
1. culturing aseptic seedlings: taking a proper amount of K326 seeds, sterilizing the surfaces of the seeds with 75% alcohol for 30 seconds, cleaning the seeds with sterile water for 3 times, soaking the seeds with 15% hydrogen peroxide for 8 minutes, cleaning the seeds with sterile water for 3 times, and soaking the seeds in the sterile water for 24 hours. The sterilized seeds are sown on an MS culture dish, after 3 leaves grow out, seedlings are transferred into a tissue culture bottle containing MS for culture, and the seedlings are cultured for about 45 days in a climatic chamber, and the strong leaves are selected for agrobacterium infection.
2. Infection with agrobacterium: taking out correctly-identified and stored agrobacterium liquid, sucking 500uL of the correctly-identified and stored agrobacterium liquid into 50mL of YEP liquid culture medium with corresponding resistance after complete melting, and culturing at 28 ℃/220rpm until OD 600 0.6. 50mL of the bacterial liquid was centrifuged at 4000rpm for 10 minutes, and the supernatant was removed. The cells were collected and resuspended to OD 600 AS was then added at a final concentration of 20mg/L for infestation at 0.6. Cutting off the edge of the leaf of aseptic seedling, cutting the leaf into 1cm along the main vein 2 Is placed into an agrobacterium infection solution for 5 minutes.
3. Co-culture and subculture: fishing out the infected leaves, sucking the agrobacterium with filter paper, spreading the leaves on a co-culture medium downwards, and placing the leaves in a climatic chamber for dark culture for 3 days. S1, subculture: leaf surfaces of leaves which are co-cultured for 3 days are upwards transferred into an S1 differentiation culture medium, and the leaves are transferred to illumination for continuous culture in a dark culture room for about 1 week until cluster buds of about 0.5cm grow on the edge of the leaves. S2, subculture: transferring the clump buds growing on the S1 to an S2 differentiation medium, removing leaf parts without clump buds, and culturing for 2 weeks by illumination until clump buds grow into seedlings. S3, subculturing: the plantlets on S2 were transferred to S3 differentiation medium and light cultured for 2 weeks. Rooting culture: removing the swelling part and yellowing leaves at the bottom of the young seedling, transferring the young seedling into a tissue culture bottle containing a rooting culture medium, and culturing for 2 weeks under illumination.
4. Obtaining transgenic tobacco: when the seedlings grow about 8 roots with the length of about 3cm, the cover of the culture flask is opened to exercise the seedlings. After 3 days, the seedlings are transferred into a flowerpot filled with sterile soil, covered with a plastic film and kept warm. And removing the preservative film after one week to enable the preservative film to grow rapidly under natural conditions.
5. Positive identification of transgenic tobacco: the obtained total RNA of transgenic tobacco was extracted and subjected to reverse transcription to obtain cDNA according to the method of example 1. Real-time quantitative PCR detection was performed using specific primers for the NtWRKY51 gene of example 2. The results showed that the expression level of the NtWRKY51 gene in both OE6 and OE9 transgenic tobacco was significantly increased compared to the control (control refers to a plant not transformed with Agrobacterium) by 36.3-fold and 41.0-fold, respectively, of the control (FIG. 3).
Identification of bacterial wilt resistance
The positive plants OE6 and OE9 of the above-mentioned pCHF3-NtWRKY 51-transformed tobacco are transferred to a greenhouse for culture, selfed and transgenic seeds are collected. Meanwhile, tobacco K326 transformed with pCHF3 empty vector is used as a control for subsequent identification of bacterial wilt resistance.
When the plants grow to 45 days, bacterial wilt inoculation and investigation methods described in the example 2 are adopted to treat tobacco plants over-expressed by the NtWRKY51 gene and tobacco control plants transformed with the pCHF3 empty vector respectively, and the disease condition of the plants is observed after 6 days. As shown in FIG. 4, tobacco plants over-expressed with the NtWRKY51 gene had significant resistance to bacterial wilt compared to the control. Meanwhile, from the propagation condition of the bacterial wilt in the tobacco root, the propagation rate of the bacterial wilt in the root of the tobacco plant with the overexpression of the NtWRKY51 gene is obviously slower than that of the control (figure 5). Taken together, it is shown that overexpression of the NtWRKY51 gene in tobacco has a remarkable enhancement effect on tobacco bacterial wilt resistance.
Sequence listing
<110> Nannong Smoke industry Limited liability company in lake
<120> tobacco NtWRKY51 gene and application thereof in regulation and control of tobacco bacterial wilt resistance
<160> 10
<170> SIPOSequenceListing 1.0
<210> 1
<211> 996
<212> DNA
<213> tobacco (Nicotiana tabacum)
<400> 1
atggattgtg ctttcaattg ggaatacaat acacttatca atgagctaac tcaaggtatt 60
gaacacacaa agcaacttag agcttacttg aggtcaatgc cttcaatttc tgaaaatcaa 120
gaattgcttc tgcagaagat actttcttct tatgagcaat ctctgttaat tctcaaatgc 180
agtggatcgg ccgttcaatc tccacagcct ctgccacaaa catgtggcgc gatcgaatct 240
tcggtttcag ttgatggaag tcctaggagt gatgacaaga aaaggatcag cgccgagact 300
ggatttgaag gtcctactga tgatggatat agctggagaa agtatggtca gaaagacatt 360
cttggtgcta aatatcctag atgcacatat cgtcacatgc aaaactgttg gacgacaaaa 420
caagtgcaaa ggtcagatga tgatcctact gtatttgaga tcacatacaa aggctctcat 480
acttgtcacc aagctactaa ttctgcacta caaccgaaat caccagaaaa tcaagaattc 540
aagaaacaag ccaactatca aacagggcaa tattcaaatg aagtactcat gaacttgaga 600
gcaaacctga gagtcgatac taatgatttg gacaagactg agacaacagc agcatgttct 660
ttctcctttc ctccaacgtt ctctagtttg acagatgaaa atcaacattt ccagatttcc 720
catgttgatg aaaatctgat gataggtggc ggctattcac cgtcttttgt ctctcctaca 780
acccctgaat caaactactt ctcaatctca agcagctgtc agatgaatgg ttttggaatg 840
gttcataacg tgcaccgttc agaatcagac ctcactgata tattctcagc caacacttcc 900
tcaacaagtt ctccaattgt gggcagcgag ttttcactag accattttga gctagatcca 960
aattttccat tcgataaccc cagatttttc tcatga 996
<210> 2
<211> 331
<212> PRT
<213> tobacco (Nicotiana tabacum)
<400> 2
Met Asp Cys Ala Phe Asn Trp Glu Tyr Asn Thr Leu Ile Asn Glu Leu
1 5 10 15
Thr Gln Gly Ile Glu His Thr Lys Gln Leu Arg Ala Tyr Leu Arg Ser
20 25 30
Met Pro Ser Ile Ser Glu Asn Gln Glu Leu Leu Leu Gln Lys Ile Leu
35 40 45
Ser Ser Tyr Glu Gln Ser Leu Leu Ile Leu Lys Cys Ser Gly Ser Ala
50 55 60
Val Gln Ser Pro Gln Pro Leu Pro Gln Thr Cys Gly Ala Ile Glu Ser
65 70 75 80
Ser Val Ser Val Asp Gly Ser Pro Arg Ser Asp Asp Lys Lys Arg Ile
85 90 95
Ser Ala Glu Thr Gly Phe Glu Gly Pro Thr Asp Asp Gly Tyr Ser Trp
100 105 110
Arg Lys Tyr Gly Gln Lys Asp Ile Leu Gly Ala Lys Tyr Pro Arg Cys
115 120 125
Thr Tyr Arg His Met Gln Asn Cys Trp Thr Thr Lys Gln Val Gln Arg
130 135 140
Ser Asp Asp Asp Pro Thr Val Phe Glu Ile Thr Tyr Lys Gly Ser His
145 150 155 160
Thr Cys His Gln Ala Thr Asn Ser Ala Leu Gln Pro Lys Ser Pro Glu
165 170 175
Asn Gln Glu Phe Lys Lys Gln Ala Asn Tyr Gln Thr Gly Gln Tyr Ser
180 185 190
Asn Glu Val Leu Met Asn Leu Arg Ala Asn Leu Arg Val Asp Thr Asn
195 200 205
Asp Leu Asp Lys Thr Glu Thr Thr Ala Ala Cys Ser Phe Ser Phe Pro
210 215 220
Pro Thr Phe Ser Ser Leu Thr Asp Glu Asn Gln His Phe Gln Ile Ser
225 230 235 240
His Val Asp Glu Asn Leu Met Ile Gly Gly Gly Tyr Ser Pro Ser Phe
245 250 255
Val Ser Pro Thr Thr Pro Glu Ser Asn Tyr Phe Ser Ile Ser Ser Ser
260 265 270
Cys Gln Met Asn Gly Phe Gly Met Val His Asn Val His Arg Ser Glu
275 280 285
Ser Asp Leu Thr Asp Ile Phe Ser Ala Asn Thr Ser Ser Thr Ser Ser
290 295 300
Pro Ile Val Gly Ser Glu Phe Ser Leu Asp His Phe Glu Leu Asp Pro
305 310 315 320
Asn Phe Pro Phe Asp Asn Pro Arg Phe Phe Ser
325 330
<210> 3
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
agaacacggg ggacgagctc 20
<210> 4
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
gatccccggg taccgagctc 20
<210> 5
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
atggattgtg ctttcaattg gg 22
<210> 6
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
tcatgagaaa aatctggggt ta 22
<210> 7
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
tgaaaatctg atgataggtg gcgg 24
<210> 8
<211> 24
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
aacttgttga ggaagtgttg gctg 24
<210> 9
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
tgaaaatctg atgataggtg 20
<210> 10
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
gtgtgtgcgc aatgaaactg 20
Claims (2)
1. The application of the tobacco NtWRKY51 gene in improving the bacterial wilt resistance of tobacco is provided, the CDS sequence of the gene is shown as SEQ ID NO.1, and the tobacco transformed plant with the improved bacterial wilt resistance of tobacco is obtained by over-expressing the tobacco NtWRKY51 gene.
2. The use according to claim 1, wherein the vector overexpressing the tobacco NtWRKY51 gene is pCHF3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110251034.8A CN115058432B (en) | 2021-03-08 | 2021-03-08 | Tobacco NtWRKY51 gene and application thereof in regulation and control of bacterial wilt resistance of tobacco |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110251034.8A CN115058432B (en) | 2021-03-08 | 2021-03-08 | Tobacco NtWRKY51 gene and application thereof in regulation and control of bacterial wilt resistance of tobacco |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115058432A CN115058432A (en) | 2022-09-16 |
CN115058432B true CN115058432B (en) | 2024-01-19 |
Family
ID=83197242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110251034.8A Active CN115058432B (en) | 2021-03-08 | 2021-03-08 | Tobacco NtWRKY51 gene and application thereof in regulation and control of bacterial wilt resistance of tobacco |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115058432B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107619830A (en) * | 2017-09-26 | 2018-01-23 | 西南大学 | A kind of plant disease resistance genes NtWRKY50 and its application in tobacco resistance to bacterial wilt |
-
2021
- 2021-03-08 CN CN202110251034.8A patent/CN115058432B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107619830A (en) * | 2017-09-26 | 2018-01-23 | 西南大学 | A kind of plant disease resistance genes NtWRKY50 and its application in tobacco resistance to bacterial wilt |
Non-Patent Citations (7)
Title |
---|
A reference genome for Nicotiana tabacum enables map-based cloning of homeologous loci implicated in nitrogen utilization efficiency;K D Edwards等;BMC Genomics;第18卷(第1期);第651-662页 * |
Genome sequence and Annotation,Edwards 2017.Nicotiana tabacum Genome Data.2017,第4-5页. * |
Ralstonia solanacearum, a widespread bacterial plant pathogen in the post-genomic era;Nemo Peeters;Mol Plant Pathol;第14卷(第7期);第651-662页 * |
Transcriptional responses of Arabidopsis thaliana during wilt disease caused by the soil-borne phytopathogenic bacterium, Ralstonia solanacearum;Jian Hu等;PLoS One;第3卷(第7期);第4页右栏 * |
普通烟草WRKY基因家族的鉴定及表达分析;向小华;吴新儒;晁江涛;杨明磊;杨帆;陈果;刘贯山;王元英;;遗传(第09期);第840-856页 * |
茄科植物WRKY转录因子的研究进展;李笑;成玉富;杨旭;;园艺学报(第01期);第170-178页 * |
高等植物WRKY转录因子家族的演化及功能研究进展;李珍;华秀婷;张积森;;热带作物学报(第02期);第405-414页 * |
Also Published As
Publication number | Publication date |
---|---|
CN115058432A (en) | 2022-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108841841B (en) | Cloning of tomato transcription factor SlbZIP6 and application thereof in high temperature stress resistance | |
CN107099540B (en) | NtFERL gene influencing tobacco pigment content and application thereof | |
CN113528537A (en) | NtQPT2 gene mutant for reducing nicotine content in tobacco leaves and application thereof | |
CN113621643A (en) | Application of GhTULP34 in regulation and control of plant resistance to abiotic adversity stress and regulation and control method | |
CN111424037B (en) | Cymbidium CgWRKY70 gene and application thereof | |
CN108517324A (en) | One NtIPMD gene for influencing tobacco axillary bud differentiation | |
CN110257401B (en) | Application of PtrMYB119 gene of Chinese white poplar in improvement of drought tolerance of tobacco | |
CN107557384B (en) | Genetic transformation system for inducing plant dwarfing and construction and application thereof | |
CN115058432B (en) | Tobacco NtWRKY51 gene and application thereof in regulation and control of bacterial wilt resistance of tobacco | |
CN113461794B (en) | Kit and method for regulating seed germination and application thereof | |
CN113234720B (en) | Wheat long-chain non-coding RNAlncR156 and application thereof in regulation and control of wheat response to drought stress | |
CN115704036B (en) | Tobacco NtDSR1 gene and application thereof | |
CN115704035B (en) | Tobacco NtDSR2 gene and application thereof | |
CN115058433B (en) | Tobacco leaf yellowing regulatory gene NtMYB2, protein and application thereof | |
CN116004646A (en) | Tobacco NtSWEET11 gene and application thereof | |
CN116004647A (en) | Tobacco NtSWEET12 gene and application thereof | |
CN115806999A (en) | Tobacco NtEIJ1 gene and application thereof | |
CN115011631B (en) | Protein for regulating drought resistance of corn at seedling stage, and coding gene and application thereof | |
CN112725367B (en) | Sweet potato sucrose invertase gene IbINV and application thereof | |
Cao et al. | Extremely simplified cut-dip-budding method for genetic transformation and gene editing in Taraxacum kok-saghyz | |
CN114350685B (en) | Application of tobacco NtTAC1 gene in leaf angle regulation and control | |
CN114807166B (en) | Liriodendron transcription factor LcbHLH02399 gene and expression protein and application thereof | |
CN114805513B (en) | Tobacco NtOEE1 gene and application thereof in regulation of stem and leaf included angle and plant height | |
CN110904110B (en) | Application of OsHAP3C gene expression reduction in rice variety with shortened heading period and prolonged growth period | |
CN115011631A (en) | Protein for regulating drought resistance of corn in seedling stage, and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |